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Background
CMR LGE detects myocardial tissue abnormalities in
hypertrophic cardiomyopathy (HCM) and aids in risk
stratification, predicting in particular heart failure and to
a lesser extent, sudden death. However, LGE quantifies
only the area of focal fibrosis only, missing diffuse fibro-
sis and assuming all LGE is the same. We hypothesized
that the total left ventricular fibrosis burden, as mea-
sured by the mean global myocardial extracellular
volume (ECVglobal) using 16 segment T1 mapping,
would be a superior marker.
Methods
Fifty-six patients with HCM from a national cardiomyo-
pathy centre were compared to 46 gender matched
healthy volunteers. All participants underwent LGE ima-
ging and ECVglobal quantification at 1.5T (Avanto, Sie-
mens). LGE was quantified using the full width at half
maximum technique. ECV quantification was performed
using dynamic contrast equilibrium at 15 minutes fol-
lowing a single bolus of 0.1mmol/kg Dotarem. The T1
was assessed using the ShMOLLI sequence pre contrast
and at dynamic equilibrium with hematocrit measure-
ment on the same day. A 16 segment left ventricular
model was used to derive the ECVglobal. In addition,
LGE+ areas and LGE- segments were separately ana-
lyzed. All patients underwent full conventional HCM
risk stratification and echocardiography.
Results
The ECVglobal was higher in HCM that in healthy
volunteers, as was the ECV in LGE+ areas and LGE-
segments. (0.32±0.04, 0.27±0.03, 0.47±0.01, 0.30±0.03,
overall P<0.0001, Figure 1). The ECVglobal correlated
with other markers of disease severity: systolic function
(by CMR), diastolic function (by echocardiography), the
occurrence of non sustained ventricular tachycardia, and
the number of conventional risk factors for sudden
death. When ECVglobal was compared to LGE extent
for predictive power, ECVglobal was the better test.
Conclusions
ECVglobal has potential to be a better CMR technique
than LGE for tissue characterization in HCM.
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Table 1 Pearson correlations and associations of the




LV ESVi r=0.35** NS NS r=0.3*
EF r=-0.35** r=-0.3* NS r=-0.3
Risk factors for sudden death ↑** NS NS NS
Non sustained ventricular
tachycardia
↑** ↑* NS ↑*
E:A ratio r=-0.3* NS r=0.41** NS
E;E’ r=0.36* NS NS r=0.36*
%LGE r=0.73*** NS r=0.54*** N/A
*** = P<0.001 ** = P<0.001 * = P<0.05
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